HYEX.US Grey Cloak Tech Inc
- Market cap
- USD 19.9M
- P/E
- -
- P/B
- 0.89x
- ROE
- -2.9%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is HYEX.US undervalued?
Graham numberThe Graham number of Grey Cloak Tech Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Grey Cloak Tech Inc fundamental analysis
No fundamental analysis for Grey Cloak Tech Inc yet.
Grey Cloak Tech Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Grey Cloak Tech Inc
Healthy Extracts Inc., through its subsidiaries, engages in acquiring, developing, patenting, marketing, and distributing plant-based nutraceuticals in the United States. It operates through Corporate and Health Supplements segments. The company's proprietary and patented products target categories within the nutraceuticals market, such as heart, brain, and immune health. It also provides heart and immune health products, including bergamot-based products in tablet and capsu…
Full company profileGrey Cloak Tech Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Grey Cloak Tech Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 128K | 67.1K | 748K | 1.28M | 1.47M | 2.25M | 2.49M | 3.11M | 4.51M | 7.36M |
| Gross Profit | 84.5K | 38.5K | 224K | -578K | 695K | 1.37M | 1.62M | 1.91M | 2.42M | 4.88M |
| Operating Income | -867K | -507K | -940K | -2.05M | -1.89M | -912K | -2.24M | -183K | -944K | -755K |
| EBITDA | -923K | -2.05M | 729K | -2.49M | -1.93M | -911K | -2.24M | -183K | -792K | -6.73K |
| Net Income | -3.56M | -3.33M | 633K | -2.58M | -1.99M | -983K | -2.47M | -841K | -881K | -660K |
| EPS | -3.96 | -0.52 | 0.01 | -0.01 | -0.01 | 0.00 | -0.84 | -0.28 | -0.05 | -0.04 |
| Balance Sheet | ||||||||||
| Total Assets | 1.12M | 85.8K | 3.45M | 3.12M | 3.03M | 2.78M | 2.64M | 2.38M | 27.8M | 32.6M |
| Total Liabilities | 2.30M | 3.65M | 4.32M | 262K | 559K | 903K | 1.68M | 1.97M | 3.80M | 10.2M |
| Shareholders' Equity | -1.18M | -3.56M | -866K | 2.85M | 2.47M | 1.88M | 955K | 410K | 24.0M | 22.4M |
| Cash & Short-term Investments | 81.7K | 485.00 | 133K | 59.2K | 222K | 65.7K | 19.4K | 112K | 147K | 190K |
| Cash Flow | ||||||||||
| Operating Cash Flow | -672K | -329K | -3.49M | -1.90M | -901K | -335K | -416K | 282K | 166K | 824K |
| Capital Expenditure | 4.19K | 23.0K | 23.0K | 7.99K | 7.99K | 7.99K | 0.00 | 0.00 | 19.3K | 0.00 |
| Free Cash Flow | -676K | -329K | -3.51M | -3.49M | -997K | -343K | -416K | 282K | 146K | 824K |
| Ratios | ||||||||||
| ROE | - | - | - | -90.3% | -80.4% | -52.3% | -259.1% | -204.9% | -3.7% | -2.9% |
| ROA | -317.3% | -3,882.0% | 18.3% | -82.7% | -65.6% | -35.3% | -93.8% | -35.4% | -3.2% | -2.0% |
| Net Profit Margin | -2,780.6% | -4,959.7% | 84.6% | -201.8% | -135.6% | -43.7% | -99.5% | -27.0% | -19.5% | -9.0% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Grey Cloak Tech Inc dividends
Grey Cloak Tech Inc has not paid dividends in the last 9 fiscal years.
Last stock split: 1:120 on Dec 29, 2023.
Who owns Grey Cloak Tech Inc
- Insiders 92.28%
- Institutions 0.00%
- Public & others 7.72%
- Shares outstanding 14.7M
- Free float 1.14M
Grey Cloak Tech Inc company profile
- Company name
- Grey Cloak Tech Inc
- Ticker
- HYEX.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Employees
- 22
- Fiscal year end
- December
- Address
- 7375 Commercial Way, Henderson, NV, United States, 89011
- Phone
- 720 463 1004
- Website
- healthyextractsinc.com
About Grey Cloak Tech Inc
Healthy Extracts Inc., through its subsidiaries, engages in acquiring, developing, patenting, marketing, and distributing plant-based nutraceuticals in the United States. It operates through Corporate and Health Supplements segments. The company's proprietary and patented products target categories within the nutraceuticals market, such as heart, brain, and immune health. It also provides heart and immune health products, including bergamot-based products in tablet and capsule form; and plant-based health technology neuro-products that enhance brain health comprising memory, cognition, focus, and neuro-energy. The company was formerly known as Grey Cloak Tech Inc. and changed its name to Healthy Extracts Inc. in October 2020. Healthy Extracts Inc. was incorporated in 2014 and is headquartered in Henderson, Nevada.
Grey Cloak Tech Inc management
3- Mr. Donald SwansonCEO & Chairman · born 1959
- Mr. Robert MaddenCFO & Secretary · born 1972
- Mr. J. Scott LandersExecutive Vice President of Sales & Marketing